Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Korman

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Journal of the American Academy of Dermatology|June 1, 1988
PemphigusN Korman
Journal of the American Academy of Dermatology|May 1, 1987
Bullous pemphigoidN Korman
Community Mental Health Journal|September 3, 2022
Comparative Effectiveness of Integrated Peer Support and Clinical Staffing Models for Community-Based Residential Mental Health Rehabilitation: A Prospective Observational StudyStephen Parker, U Arnautovska, N Korman, et al.
Epidemiology and Psychiatric Sciences|March 12, 2020
Community-care unit model of residential mental health rehabilitation services in Queensland, Australia: predicting outcomes of consumers 1-year post dischargeS Parker, U Arnautovska, D Siskind, et al.
The American Journal of the Medical Sciences|August 1, 1997
Pityriasis rubra pilaris: an unusual cutaneous complication of AIDSR A Bonomo, N Korman, L Nagashima-Whalen, et al.
Journal of the American Academy of Dermatology|January 6, 2001
The impact of tacrolimus ointment on health-related quality of life of adult and pediatric patients with atopic dermatitisL Drake, M Prendergast, R Maher, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|October 4, 2016
Treatment outcomes with ixekizumab in patients with moderate-to-severe psoriasis who have or have not received prior biological therapies: an integrated analysis of two Phase III randomized studiesA B Gottlieb, J-P Lacour, N Korman, et al.
The British Journal of Dermatology|June 14, 2005
Efficacy and tolerability of three different doses of oral pimecrolimus in the treatment of moderate to severe atopic dermatitis: a randomized controlled trialK Wolff, C Fleming, J Hanifin, et al.
The British Journal of Dermatology|October 14, 2014
Long-term efficacy and safety of ustekinumab, with and without dosing adjustment, in patients with moderate-to-severe psoriasis: results from the PHOENIX 2 study through 5 years of follow-upR G Langley, M Lebwohl, G G Krueger, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Journal of the American Academy of Dermatology|June 1, 1988
PemphigusN Korman
Journal of the American Academy of Dermatology|May 1, 1987
Bullous pemphigoidN Korman
Community Mental Health Journal|September 3, 2022
Comparative Effectiveness of Integrated Peer Support and Clinical Staffing Models for Community-Based Residential Mental Health Rehabilitation: A Prospective Observational StudyStephen Parker, U Arnautovska, N Korman, et al.
Epidemiology and Psychiatric Sciences|March 12, 2020
Community-care unit model of residential mental health rehabilitation services in Queensland, Australia: predicting outcomes of consumers 1-year post dischargeS Parker, U Arnautovska, D Siskind, et al.
The American Journal of the Medical Sciences|August 1, 1997
Pityriasis rubra pilaris: an unusual cutaneous complication of AIDSR A Bonomo, N Korman, L Nagashima-Whalen, et al.
Journal of the American Academy of Dermatology|January 6, 2001
The impact of tacrolimus ointment on health-related quality of life of adult and pediatric patients with atopic dermatitisL Drake, M Prendergast, R Maher, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|October 4, 2016
Treatment outcomes with ixekizumab in patients with moderate-to-severe psoriasis who have or have not received prior biological therapies: an integrated analysis of two Phase III randomized studiesA B Gottlieb, J-P Lacour, N Korman, et al.
The British Journal of Dermatology|June 14, 2005
Efficacy and tolerability of three different doses of oral pimecrolimus in the treatment of moderate to severe atopic dermatitis: a randomized controlled trialK Wolff, C Fleming, J Hanifin, et al.
The British Journal of Dermatology|October 14, 2014
Long-term efficacy and safety of ustekinumab, with and without dosing adjustment, in patients with moderate-to-severe psoriasis: results from the PHOENIX 2 study through 5 years of follow-upR G Langley, M Lebwohl, G G Krueger, et al.
Pageof 1